Press Corner

Press Corner [1]

The media relations team is Sciensano’s official voice towards the media. It communicates about Sciensano’s research outcomes and expert advice, organises press events and issues press material. For topical information on public health issues, consult the fact sheets in the Your Health [2] section. If you are a journalist and you cannot find what you are looking for, please contact Sciensano’s media relations team.

The latest news items about the coronavirus and Covid-19 can be found on the website www.info-coronavirus.be [3] of the FPS Public Health.

Press releases and news

Topic

Belgium drops from 8th to 15th place on the European ladder of healthy life years [4]

[5]

Published on: 16-7-2018

Belgians lose on average 73 days due to disability or premature mortality.

Associated health topics: Health and disease monitoring [5]

Sciensano joins a European collaboration for developing vaccine adjuvants [6]

[7]

Published on: 29-5-2018

Scientists from Sciensano have joined the European Network of Vaccine Adjuvants (ENOVA), which brings together European experts and stakeholders working in different... Read more [6]

Associated health topics: Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories [7]

Does HPV vaccination prevent the development of cervical cancer? [8]

[5]

Published on: 9-5-2018

New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in... Read more [8]

Associated health topics: Human papillomavirus (HPV) and cervical cancer [9]

Working visit of Vytenis Andriukaitis, European Commissioner for Health and Food Safety [10]

[5]

Published on: 3-5-2017

On May 2nd 2017, as part of a day dedicated to Belgium, Vytenis Andriukaitis, European Commissioner for Health and Food Safety, visited the premises of the future Belgian Health Institute. Named ‘... Read more [10]

Associated health topics: Health and disease monitoring [5]

The Belgian Institute of Public Health (WIV-ISP) participates in the development of a new vaccine against rabies and yellow fever [11]

[7]

Published on: 4-4-2017

As part of the 'RABYD-VAX *' project, funded by the Horizon 2020 programme of the European Union, the Belgian Scientific Institute of... Read more [11]

Issue 185 | New Health at a Glance report: lending a hand, not pointing the finger [12]

Could not find related health topics domains

Published on: 9-12-2016

[12]

« first [13]
‹ previous [14]
…
13 [15]
14 [16]
15 [17]
16 [14]
17
18 [18]
19 [19]
20 [20]
21 [21]
next › [18]
last » [21]